Stifel Nicolaus Lowers Xylem (NYSE:XYL) Price Target to $150.00

Xylem (NYSE:XYLFree Report) had its target price trimmed by Stifel Nicolaus from $166.00 to $150.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has a buy rating on the industrial products company’s stock.

Other equities analysts have also recently issued reports about the stock. Robert W. Baird decreased their target price on shares of Xylem from $175.00 to $154.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. TD Cowen cut their price target on Xylem from $138.00 to $125.00 and set a “hold” rating for the company in a research note on Wednesday, November 6th. Citigroup lowered their price target on Xylem from $148.00 to $147.00 and set a “buy” rating on the stock in a research report on Monday, January 13th. Royal Bank of Canada cut their price objective on Xylem from $163.00 to $162.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Finally, Wolfe Research reiterated a “peer perform” rating on shares of Xylem in a research report on Thursday, December 12th. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $150.50.

Check Out Our Latest Research Report on XYL

Xylem Stock Down 0.0 %

XYL stock opened at $121.53 on Friday. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.96 and a quick ratio of 1.42. The firm’s fifty day simple moving average is $120.88 and its 200-day simple moving average is $128.41. Xylem has a 12 month low of $111.72 and a 12 month high of $146.08. The company has a market capitalization of $29.53 billion, a P/E ratio of 35.54, a price-to-earnings-growth ratio of 2.05 and a beta of 1.06.

Xylem (NYSE:XYLGet Free Report) last issued its earnings results on Thursday, October 31st. The industrial products company reported $1.11 EPS for the quarter, hitting analysts’ consensus estimates of $1.11. The firm had revenue of $2.10 billion for the quarter, compared to the consensus estimate of $2.17 billion. Xylem had a return on equity of 9.61% and a net margin of 9.85%. The company’s revenue was up .2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.99 earnings per share. As a group, equities research analysts forecast that Xylem will post 4.23 earnings per share for the current year.

Xylem Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 24th. Stockholders of record on Tuesday, November 26th were issued a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 1.18%. The ex-dividend date of this dividend was Tuesday, November 26th. Xylem’s dividend payout ratio is currently 42.11%.

Institutional Trading of Xylem

Hedge funds and other institutional investors have recently modified their holdings of the stock. State Street Corp grew its holdings in shares of Xylem by 1.9% in the third quarter. State Street Corp now owns 10,329,494 shares of the industrial products company’s stock valued at $1,394,792,000 after purchasing an additional 189,820 shares during the period. Geode Capital Management LLC grew its stake in shares of Xylem by 1.0% in the 3rd quarter. Geode Capital Management LLC now owns 5,668,755 shares of the industrial products company’s stock valued at $762,804,000 after buying an additional 54,877 shares during the period. Swedbank AB increased its holdings in shares of Xylem by 23.1% during the 4th quarter. Swedbank AB now owns 3,683,201 shares of the industrial products company’s stock worth $427,325,000 after buying an additional 691,618 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Xylem by 1.0% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,449,307 shares of the industrial products company’s stock valued at $465,760,000 after buying an additional 32,645 shares during the period. Finally, Impax Asset Management Group plc lifted its holdings in Xylem by 1.0% in the third quarter. Impax Asset Management Group plc now owns 1,677,816 shares of the industrial products company’s stock valued at $226,555,000 after acquiring an additional 15,825 shares during the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.

About Xylem

(Get Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Read More

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.